Disclosing drug makers payments to docs gets boost
AP/Yahoo News, May 14, 2008
Eli Lilly and Co. have endorsed legislation that would require prescription drug makers to disclose payments to doctors. The legislation addresses concerns that payments, such as picking up paying travel expenses for a conference at an exotic locale, can influence a doctor's prescribing habits. The legislation would not ban the payments, but require that companies report them beginning March 31, 2011. It would also pre-empt laws in the few states that already require drug makers to disclose their payments to doctors.
Most Viewed
Most Emailed
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- How Chargemaster Data May Affect Hospital Revenue
- Primary Care Docs Average More Hospital Revenue Than Specialists
- House Lawmakers Grill CMS Over Health Exchange Navigators
- Fortunately, Angelina Jolie Isn't On Medicare
- ED Physicians Key to Half of Hospital Admissions
- Don't Let Nurses Sink Your Bottom Line
- Insurer's App Aims to Lower Healthcare Costs, Securely
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- Uncompensated Care Faces a Double Hit in Some States
